185 related articles for article (PubMed ID: 16734108)
1. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia.
Weiss DJ; Brazzell JL
J Vet Intern Med; 2006; 20(3):682-6. PubMed ID: 16734108
[TBL] [Abstract][Full Text] [Related]
2. Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism.
Wells R; Guth A; Lappin M; Dow S
J Vet Intern Med; 2009; 23(2):295-300. PubMed ID: 19192144
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant microparticles in dogs with immune-mediated hemolytic anemia.
Kidd L; Geddings J; Hisada Y; Sueda M; Concannon T; Nichols T; Merricks E; Mackman N
J Vet Intern Med; 2015; 29(3):908-16. PubMed ID: 25871966
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia.
Zoia A; Gerou-Ferriani M; Drigo M; Caldin M
J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969
[TBL] [Abstract][Full Text] [Related]
5. Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia.
Kidd L; Mackman N
J Vet Emerg Crit Care (San Antonio); 2013; 23(1):3-13. PubMed ID: 23356703
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of platelet activation in canine immune-mediated haemolytic anaemia.
Ridyard AE; Shaw DJ; Milne EM
J Small Anim Pract; 2010 Jun; 51(6):296-304. PubMed ID: 20618628
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs.
Helmond SE; Polzin DJ; Armstrong PJ; Finke M; Smith SA
J Vet Intern Med; 2010; 24(3):597-605. PubMed ID: 20384956
[TBL] [Abstract][Full Text] [Related]
8. High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia.
Piek CJ; Brinkhof B; Teske E; Rothuizen J; Dekker A; Penning LC
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):346-54. PubMed ID: 21899896
[TBL] [Abstract][Full Text] [Related]
9. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia.
Tan E; Bienzle D; Shewen P; Kruth S; Wood D
Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.
Lawson C; Smith SA; O'Brien M; McMichael M
J Vet Intern Med; 2018 Jan; 32(1):128-134. PubMed ID: 29214674
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of flow cytometric and automated methods for detection of activated platelets in dogs with inflammatory disease.
Moritz A; Walcheck BK; Weiss DJ
Am J Vet Res; 2005 Feb; 66(2):325-9. PubMed ID: 15757135
[TBL] [Abstract][Full Text] [Related]
12. Thromboelastographic assessment of the contribution of platelets and clotting proteases to the hypercoagulable state of dogs with immune-mediated hemolytic anemia.
Hamzianpour N; Chan DL
J Vet Emerg Crit Care (San Antonio); 2016; 26(2):295-9. PubMed ID: 25918856
[TBL] [Abstract][Full Text] [Related]
13. Urinary 11-dehydrothromboxane B
Conway EA; Evans NP; Ridyard AE
J Vet Intern Med; 2022 Jan; 36(1):86-96. PubMed ID: 34859495
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of blood type, breed, sex, and bacteremia in dogs with immune-mediated hemolytic anemia.
Miller SA; Hohenhaus AE; Hale AS
J Am Vet Med Assoc; 2004 Jan; 224(2):232-5. PubMed ID: 14736067
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia.
Griebsch C; Arndt G; Raila J; Schweigert FJ; Kohn B
Vet Clin Pathol; 2009 Dec; 38(4):421-5. PubMed ID: 19392754
[TBL] [Abstract][Full Text] [Related]
16. The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.
Paes G; Paepe D; Meyer E; Kristensen AT; Duchateau L; Campos M; Daminet S
Acta Vet Scand; 2013 Oct; 55(1):74. PubMed ID: 24160183
[TBL] [Abstract][Full Text] [Related]
17. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.
Garden OA; Kidd L; Mexas AM; Chang YM; Jeffery U; Blois SL; Fogle JE; MacNeill AL; Lubas G; Birkenheuer A; Buoncompagni S; Dandrieux JRS; Di Loria A; Fellman CL; Glanemann B; Goggs R; Granick JL; LeVine DN; Sharp CR; Smith-Carr S; Swann JW; Szladovits B
J Vet Intern Med; 2019 Mar; 33(2):313-334. PubMed ID: 30806491
[TBL] [Abstract][Full Text] [Related]
18. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs.
Kjelgaard-Hansen M; Goggs R; Wiinberg B; Chan DL
J Vet Intern Med; 2011; 25(1):76-82. PubMed ID: 21092010
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated hemolytic anemia.
Breuhl EL; Moore G; Brooks MB; Scott-Moncrieff JC
J Am Anim Hosp Assoc; 2009; 45(3):125-33. PubMed ID: 19411648
[TBL] [Abstract][Full Text] [Related]
20. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.
Grobman M; Outi H; Rindt H; Reinero C
J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
